Efficient and Selective Biosynthesis of a Precursor-Directed FK506 Analogue: Paving the Way for Click Chemistry

The medically important immunosuppressant FK506 is a structurally complex macrolactone biosynthesized by a combined polyketide synthase and a nonribosomal peptide synthetase enzyme complex. Its acyltransferase domain 4 (AT4) selects an unusual extender unit, resulting in an allyl moiety on carbon 21...

Full description

Saved in:
Bibliographic Details
Published inJournal of natural products (Washington, D.C.) Vol. 88; no. 3; pp. 619 - 630
Main Authors Goranovič, Dušan, Jenko, Branko, Ramšak, Barbara, Podgoršek Berke, Ajda, Bedrač, Leon, Horvat, Jaka, Šala, Martin, Makuc, Damjan, Carriche, Guilhermina M., Silva, Luana, Lopez Krol, Aleksandra, Pšeničnik, Alen, Durán Alonso, María Beatriz, Avbelj, Martina, Stavber, Stojan, Plavec, Janez, Sparwasser, Tim, Müller, Rolf, Kosec, Gregor, Fujs, Štefan, Petković, Hrvoje
Format Journal Article
LanguageEnglish
Published United States American Chemical Society and American Society of Pharmacognosy 28.03.2025
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The medically important immunosuppressant FK506 is a structurally complex macrolactone biosynthesized by a combined polyketide synthase and a nonribosomal peptide synthetase enzyme complex. Its acyltransferase domain 4 (AT4) selects an unusual extender unit, resulting in an allyl moiety on carbon 21 of the macrolactone backbone. Based on the AT4 domain, chemobiosynthetic processes have been developed that enable the introduction of diverse moieties at the carbon 21 position. However, the novel moieties that were introduced into the polyketide backbone are chemically inert. Reported here is a novel and efficient chemobiosynthetic approach that ensures high titer of an FK506 analogue containing a propargyl moiety. The novel FK506 analogue displays lower immunosuppression activity than FK506 with significantly reduced cytotoxicity. More importantly, the propargyl moiety contains a terminal alkyl group, which makes click chemistry reactions possible; this approach may potentially be translated to other medically important drugs of polyketide origin.
AbstractList The medically important immunosuppressant FK506 is a structurally complex macrolactone biosynthesized by a combined polyketide synthase and a nonribosomal peptide synthetase enzyme complex. Its acyltransferase domain 4 (AT4) selects an unusual extender unit, resulting in an allyl moiety on carbon 21 of the macrolactone backbone. Based on the AT4 domain, chemobiosynthetic processes have been developed that enable the introduction of diverse moieties at the carbon 21 position. However, the novel moieties that were introduced into the polyketide backbone are chemically inert. Reported here is a novel and efficient chemobiosynthetic approach that ensures high titer of an FK506 analogue containing a propargyl moiety. The novel FK506 analogue displays lower immunosuppression activity than FK506 with significantly reduced cytotoxicity. More importantly, the propargyl moiety contains a terminal alkyl group, which makes click chemistry reactions possible; this approach may potentially be translated to other medically important drugs of polyketide origin.The medically important immunosuppressant FK506 is a structurally complex macrolactone biosynthesized by a combined polyketide synthase and a nonribosomal peptide synthetase enzyme complex. Its acyltransferase domain 4 (AT4) selects an unusual extender unit, resulting in an allyl moiety on carbon 21 of the macrolactone backbone. Based on the AT4 domain, chemobiosynthetic processes have been developed that enable the introduction of diverse moieties at the carbon 21 position. However, the novel moieties that were introduced into the polyketide backbone are chemically inert. Reported here is a novel and efficient chemobiosynthetic approach that ensures high titer of an FK506 analogue containing a propargyl moiety. The novel FK506 analogue displays lower immunosuppression activity than FK506 with significantly reduced cytotoxicity. More importantly, the propargyl moiety contains a terminal alkyl group, which makes click chemistry reactions possible; this approach may potentially be translated to other medically important drugs of polyketide origin.
The medically important immunosuppressant FK506 is a structurally complex macrolactone biosynthesized by a combined polyketide synthase and a nonribosomal peptide synthetase enzyme complex. Its acyltransferase domain 4 (AT4) selects an unusual extender unit, resulting in an allyl moiety on carbon 21 of the macrolactone backbone. Based on the AT4 domain, chemobiosynthetic processes have been developed that enable the introduction of diverse moieties at the carbon 21 position. However, the novel moieties that were introduced into the polyketide backbone are chemically inert. Reported here is a novel and efficient chemobiosynthetic approach that ensures high titer of an FK506 analogue containing a propargyl moiety. The novel FK506 analogue displays lower immunosuppression activity than FK506 with significantly reduced cytotoxicity. More importantly, the propargyl moiety contains a terminal alkyl group, which makes click chemistry reactions possible; this approach may potentially be translated to other medically important drugs of polyketide origin.
The medically important immunosuppressant FK506 is a structurally complex macrolactone biosynthesized by a combined polyketide synthase and a nonribosomal peptide synthetase enzyme complex. Its acyltransferase domain 4 (AT4) selects an unusual extender unit, resulting in an allyl moiety on carbon 21 of the macrolactone backbone. Based on the AT4 domain, chemobiosynthetic processes have been developed that enable the introduction of diverse moieties at the carbon 21 position. However, the novel moieties that were introduced into the polyketide backbone are chemically inert. Reported here is a novel and efficient chemobiosynthetic approach that ensures high titer of an FK506 analogue containing a propargyl moiety. The novel FK506 analogue displays lower immunosuppression activity than FK506 with significantly reduced cytotoxicity. More importantly, the propargyl moiety contains a terminal alkyl group, which makes click chemistry reactions possible; this approach may potentially be translated to other medically important drugs of polyketide origin.
Author Goranovič, Dušan
Horvat, Jaka
Pšeničnik, Alen
Avbelj, Martina
Jenko, Branko
Podgoršek Berke, Ajda
Makuc, Damjan
Carriche, Guilhermina M.
Fujs, Štefan
Bedrač, Leon
Silva, Luana
Stavber, Stojan
Petković, Hrvoje
Durán Alonso, María Beatriz
Plavec, Janez
Ramšak, Barbara
Šala, Martin
Sparwasser, Tim
Lopez Krol, Aleksandra
Müller, Rolf
Kosec, Gregor
AuthorAffiliation Department of Biochemistry and Molecular Biology and Physiology
Institute of Medical Microbiology and Hygiene and Research Center for Immunotherapy (FZI)
Department of Physical and Organic Chemistry
University of Ljubljana
Biotechnical Faculty, Department of Food Science and Technology
Acies Bio, d.o.o
EN → FIST Centre of Excellence
Faculty of Chemistry and Chemical Technology
Saarland University
University Medical Center of the Johannes Gutenberg-University
Jožef Stefan Institute
National Institute of Chemistry
University of Valladolid
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), and Department of Pharmacy
Institute of Infection Immunology, TWINCORE, Centre for Experimental and Clinical Infection Research, a Joint Venture Between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI)
Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP)
AuthorAffiliation_xml – name: University Medical Center of the Johannes Gutenberg-University
– name: Department of Biochemistry and Molecular Biology and Physiology
– name: Saarland University
– name: Acies Bio, d.o.o
– name: University of Ljubljana
– name: Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), and Department of Pharmacy
– name: Faculty of Chemistry and Chemical Technology
– name: Biotechnical Faculty, Department of Food Science and Technology
– name: University of Valladolid
– name: Department of Physical and Organic Chemistry
– name: EN → FIST Centre of Excellence
– name: National Institute of Chemistry
– name: Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP)
– name: Institute of Infection Immunology, TWINCORE, Centre for Experimental and Clinical Infection Research, a Joint Venture Between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI)
– name: Institute of Medical Microbiology and Hygiene and Research Center for Immunotherapy (FZI)
– name: Jožef Stefan Institute
Author_xml – sequence: 1
  givenname: Dušan
  surname: Goranovič
  fullname: Goranovič, Dušan
  organization: Acies Bio, d.o.o
– sequence: 2
  givenname: Branko
  surname: Jenko
  fullname: Jenko, Branko
  organization: Acies Bio, d.o.o
– sequence: 3
  givenname: Barbara
  surname: Ramšak
  fullname: Ramšak, Barbara
  organization: Biotechnical Faculty, Department of Food Science and Technology
– sequence: 4
  givenname: Ajda
  surname: Podgoršek Berke
  fullname: Podgoršek Berke, Ajda
  organization: Acies Bio, d.o.o
– sequence: 5
  givenname: Leon
  surname: Bedrač
  fullname: Bedrač, Leon
  organization: Acies Bio, d.o.o
– sequence: 6
  givenname: Jaka
  surname: Horvat
  fullname: Horvat, Jaka
  organization: Acies Bio, d.o.o
– sequence: 7
  givenname: Martin
  orcidid: 0000-0001-7845-860X
  surname: Šala
  fullname: Šala, Martin
  organization: National Institute of Chemistry
– sequence: 8
  givenname: Damjan
  surname: Makuc
  fullname: Makuc, Damjan
  organization: National Institute of Chemistry
– sequence: 9
  givenname: Guilhermina M.
  surname: Carriche
  fullname: Carriche, Guilhermina M.
  organization: Institute of Infection Immunology, TWINCORE, Centre for Experimental and Clinical Infection Research, a Joint Venture Between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI)
– sequence: 10
  givenname: Luana
  orcidid: 0000-0001-7297-9586
  surname: Silva
  fullname: Silva, Luana
  organization: Institute of Infection Immunology, TWINCORE, Centre for Experimental and Clinical Infection Research, a Joint Venture Between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI)
– sequence: 11
  givenname: Aleksandra
  surname: Lopez Krol
  fullname: Lopez Krol, Aleksandra
  organization: Institute of Infection Immunology, TWINCORE, Centre for Experimental and Clinical Infection Research, a Joint Venture Between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI)
– sequence: 12
  givenname: Alen
  surname: Pšeničnik
  fullname: Pšeničnik, Alen
  organization: Biotechnical Faculty, Department of Food Science and Technology
– sequence: 13
  givenname: María Beatriz
  surname: Durán Alonso
  fullname: Durán Alonso, María Beatriz
  organization: University of Valladolid
– sequence: 14
  givenname: Martina
  surname: Avbelj
  fullname: Avbelj, Martina
  organization: Biotechnical Faculty, Department of Food Science and Technology
– sequence: 15
  givenname: Stojan
  surname: Stavber
  fullname: Stavber, Stojan
  organization: Jožef Stefan Institute
– sequence: 16
  givenname: Janez
  orcidid: 0000-0003-1570-8602
  surname: Plavec
  fullname: Plavec, Janez
  organization: University of Ljubljana
– sequence: 17
  givenname: Tim
  surname: Sparwasser
  fullname: Sparwasser, Tim
  organization: Institute of Infection Immunology, TWINCORE, Centre for Experimental and Clinical Infection Research, a Joint Venture Between the Medical School Hannover (MHH) and the Helmholtz Centre for Infection Research (HZI)
– sequence: 18
  givenname: Rolf
  orcidid: 0000-0002-1042-5665
  surname: Müller
  fullname: Müller, Rolf
  organization: Saarland University
– sequence: 19
  givenname: Gregor
  surname: Kosec
  fullname: Kosec, Gregor
  organization: Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP)
– sequence: 20
  givenname: Štefan
  surname: Fujs
  fullname: Fujs, Štefan
  organization: Centre of Excellence for Integrated Approaches in Chemistry and Biology of Proteins (CIPKeBiP)
– sequence: 21
  givenname: Hrvoje
  orcidid: 0000-0003-1377-9845
  surname: Petković
  fullname: Petković, Hrvoje
  email: hrvoje.petkovic@bf.uni-lj.si
  organization: Biotechnical Faculty, Department of Food Science and Technology
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40062573$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1vEzEQhi1URNPCP0DIRy4bxp-b5YJKaAFRiUqAOFpe72zisrFTezdS_j2GpBVcQD7Y0jzvaMbPGTkJMSAhzxnMGXD2yro8vw123KbYzaUDEI18RGZMcag0cHVCZsC0qMRCy1NylvMtFAYa9YScSgDNVS1mJF72vXcew0ht6OgXHNCNfof0rY95H8Y1Zp9p7KmlNwndlHJM1TtfniN29OqTAk0vgh3iasLX9MbufFjRkqLf7Z72MdHl4N0Pulzjxucx7Z-Sx70dMj473ufk29Xl1-WH6vrz-4_Li-vKCs3HSrQCdNsKwRuUTjomAblQCysdthJ4p-pOcZStroVQQmkumQDEBau5BtuLc_Lm0Hc7tRvsXFkw2cFsk9_YtDfRevN3Jfi1WcWdYaxR5YjS4eWxQ4p3E-bRlA0cDoMNGKdsBAfNGibKH_8XZbXSC8U0FPTFn3M9DHRvpADyALgUc07YPyAMzC_xpog39-LNUXyJwSH2uxqnVJzkf0d-Agx6s9c
Cites_doi 10.3389/fphar.2018.01425
10.1517/14656566.2013.751374
10.1111/febs.13296
10.1146/annurev.mi.47.100193.004303
10.1021/acs.bioconjchem.1c00247
10.1021/sb3001062
10.1074/jbc.M109.059600
10.1002/9780470559277.ch110148
10.1038/ncomms13609
10.1039/B707678A
10.1038/ja.2016.137
10.1002/anie.200462784
10.1021/ja108399b
10.1002/bit.10086
10.1080/17460441.2019.1614910
10.4049/jimmunol.1390055
10.1016/S1074-5521(97)90314-8
10.1039/C1NP00082A
10.2174/1568014033483761
10.1038/sj.jim.7000206
10.1021/acs.jnatprod.0c00767
10.1016/j.ymben.2011.11.003
10.1021/acs.jnatprod.9b00144
10.1016/j.phrs.2024.107438
10.1016/j.drudis.2015.08.004
10.1021/cr200409f
10.1007/s00253-012-4364-x
10.1007/s00253-013-5362-3
10.2165/00003495-200565060-00011
10.1007/s10295-003-0062-0
ContentType Journal Article
Copyright 2025 The Authors. Published by American Chemical Society and American Society of Pharmacognosy
2025 The Authors. Published by American Chemical Society and American Society of Pharmacognosy 2025 The Authors
Copyright_xml – notice: 2025 The Authors. Published by American Chemical Society and American Society of Pharmacognosy
– notice: 2025 The Authors. Published by American Chemical Society and American Society of Pharmacognosy 2025 The Authors
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
DOI 10.1021/acs.jnatprod.4c00394
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic


MEDLINE
AGRICOLA
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
Pharmacy, Therapeutics, & Pharmacology
EISSN 1520-6025
EndPage 630
ExternalDocumentID PMC11959593
40062573
10_1021_acs_jnatprod_4c00394
c144231916
Genre Journal Article
GroupedDBID ---
-~X
4.4
55A
5GY
5VS
7~N
AABXI
AAHBH
AAWTL
ABJNI
ABMVS
ABOCM
ABQRX
ABUCX
ACGFS
ACJ
ACNCT
ACS
ADHLV
AEESW
AENEX
AFEFF
AGXLV
AHGAQ
ALMA_UNASSIGNED_HOLDINGS
AQSVZ
BAANH
CS3
CUPRZ
DU5
EBS
ED~
F5P
GGK
GNL
IH9
IHE
JG~
LG6
P2P
ROL
TN5
UI2
VF5
VG9
W1F
XKZ
YZZ
AAYXX
ABBLG
ABLBI
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
ID FETCH-LOGICAL-a362t-3b306bb3329e4c4c140e2358a4ceb402d57d52e4b6733535624130ee817260af3
IEDL.DBID ACS
ISSN 0163-3864
1520-6025
IngestDate Thu Aug 21 18:38:38 EDT 2025
Wed Jul 02 03:22:34 EDT 2025
Fri Jul 11 16:12:40 EDT 2025
Fri Aug 01 03:41:21 EDT 2025
Tue Jul 01 05:10:34 EDT 2025
Mon Mar 31 03:20:05 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License https://creativecommons.org/licenses/by/4.0
Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a362t-3b306bb3329e4c4c140e2358a4ceb402d57d52e4b6733535624130ee817260af3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0001-7845-860X
0000-0003-1377-9845
0000-0001-7297-9586
0000-0002-1042-5665
0000-0003-1570-8602
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC11959593
PMID 40062573
PQID 3175685160
PQPubID 23479
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11959593
proquest_miscellaneous_3206191316
proquest_miscellaneous_3175685160
pubmed_primary_40062573
crossref_primary_10_1021_acs_jnatprod_4c00394
acs_journals_10_1021_acs_jnatprod_4c00394
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-Mar-28
PublicationDateYYYYMMDD 2025-03-28
PublicationDate_xml – month: 03
  year: 2025
  text: 2025-Mar-28
  day: 28
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of natural products (Washington, D.C.)
PublicationTitleAlternate J. Nat. Prod
PublicationYear 2025
Publisher American Chemical Society and American Society of Pharmacognosy
Publisher_xml – name: American Chemical Society and American Society of Pharmacognosy
References ref9/cit9
ref6/cit6
ref3/cit3
ref27/cit27
ref18/cit18
ref11/cit11
ref25/cit25
ref16/cit16
ref29/cit29
ref23/cit23
ref14/cit14
ref8/cit8
ref5/cit5
ref2/cit2
ref28/cit28
IBM Corp. (ref32/cit32) 2017
ref20/cit20
ref17/cit17
ref10/cit10
ref26/cit26
ref19/cit19
ref21/cit21
ref12/cit12
ref15/cit15
ref22/cit22
ref13/cit13
ref33/cit33
ref4/cit4
ref30/cit30
ref1/cit1
ref24/cit24
Kieser T. (ref31/cit31) 2000
ref7/cit7
References_xml – ident: ref2/cit2
  doi: 10.3389/fphar.2018.01425
– ident: ref3/cit3
  doi: 10.1517/14656566.2013.751374
– ident: ref29/cit29
  doi: 10.1111/febs.13296
– ident: ref1/cit1
  doi: 10.1146/annurev.mi.47.100193.004303
– ident: ref21/cit21
  doi: 10.1021/acs.bioconjchem.1c00247
– volume-title: IBM SPSS Statistics for Windows [Internet]
  year: 2017
  ident: ref32/cit32
– ident: ref11/cit11
  doi: 10.1021/sb3001062
– ident: ref16/cit16
  doi: 10.1074/jbc.M109.059600
– ident: ref25/cit25
  doi: 10.1002/9780470559277.ch110148
– ident: ref17/cit17
  doi: 10.1038/ncomms13609
– ident: ref7/cit7
  doi: 10.1039/B707678A
– ident: ref26/cit26
  doi: 10.1038/ja.2016.137
– ident: ref9/cit9
  doi: 10.1002/anie.200462784
– ident: ref15/cit15
  doi: 10.1021/ja108399b
– ident: ref20/cit20
  doi: 10.1002/bit.10086
– ident: ref23/cit23
  doi: 10.1080/17460441.2019.1614910
– ident: ref4/cit4
  doi: 10.4049/jimmunol.1390055
– ident: ref19/cit19
  doi: 10.1016/S1074-5521(97)90314-8
– ident: ref14/cit14
  doi: 10.1039/C1NP00082A
– ident: ref5/cit5
  doi: 10.2174/1568014033483761
– ident: ref8/cit8
  doi: 10.1038/sj.jim.7000206
– ident: ref10/cit10
  doi: 10.1021/acs.jnatprod.0c00767
– ident: ref18/cit18
  doi: 10.1016/j.ymben.2011.11.003
– ident: ref30/cit30
  doi: 10.1021/acs.jnatprod.9b00144
– volume-title: Practical Streptomyces Genetics
  year: 2000
  ident: ref31/cit31
– ident: ref33/cit33
  doi: 10.1016/j.phrs.2024.107438
– ident: ref24/cit24
  doi: 10.1016/j.drudis.2015.08.004
– ident: ref22/cit22
  doi: 10.1021/cr200409f
– ident: ref28/cit28
  doi: 10.1007/s00253-012-4364-x
– ident: ref27/cit27
– ident: ref12/cit12
  doi: 10.1007/s00253-013-5362-3
– ident: ref6/cit6
  doi: 10.2165/00003495-200565060-00011
– ident: ref13/cit13
  doi: 10.1007/s10295-003-0062-0
SSID ssj0003095
Score 2.4494479
Snippet The medically important immunosuppressant FK506 is a structurally complex macrolactone biosynthesized by a combined polyketide synthase and a nonribosomal...
The medically important immunosuppressant FK506 is a structurally complex macrolactone biosynthesized by a combined polyketide synthase and a nonribosomal...
SourceID pubmedcentral
proquest
pubmed
crossref
acs
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 619
SubjectTerms biosynthesis
carbon
Click Chemistry
cytotoxicity
domain
Humans
immunosuppression
immunosuppressive agents
Immunosuppressive Agents - chemistry
Immunosuppressive Agents - pharmacology
moieties
Molecular Structure
nonribosomal peptides
Peptide Synthases - metabolism
polyketide synthases
Polyketide Synthases - metabolism
polyketides
Tacrolimus - analogs & derivatives
Tacrolimus - chemistry
Tacrolimus - metabolism
Title Efficient and Selective Biosynthesis of a Precursor-Directed FK506 Analogue: Paving the Way for Click Chemistry
URI http://dx.doi.org/10.1021/acs.jnatprod.4c00394
https://www.ncbi.nlm.nih.gov/pubmed/40062573
https://www.proquest.com/docview/3175685160
https://www.proquest.com/docview/3206191316
https://pubmed.ncbi.nlm.nih.gov/PMC11959593
Volume 88
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BEaIXHstroaBBQpWQmm1iO96kt2rVVQUCVmoreotsxxFLqwRtsofw6xnnsdttVR6XHBLHyVjjmW9szzcA76WMxlEaZF5obOQJSZfYUtRqjBZRmNo0Fi7B-fMXeXwmPp6H5-tA8foOPgv2lSlHP3JVNQZFGJdMKu7CPUYfccHW4eRkZXm5H7dHFiX3eCRFnyp3Sy_OIZly0yHdQJnXD0te8T7TR_C1z-FpD51cjJaVHplfNykd_1Gwx_CwA6J42GrOE7hj8wHcb0tT1gN4MOkrwQ1gd9byW9d7eLpO1yr3cBdna-br-ikURw0hBYmAKk_xpKmxQ-YUqduyzglrlvMSiwwVzhZuob8sFl5rdG2K00-hL9GxpLjlpAOcKbfYgfQWflM1ErrGyeXcXODq157B2fTodHLsdRUdPEWOsvK4pghFa85ZbIURhqI763J1lTBWUySbhuM0ZFZoOeY85ITNnI-1NiKYJX2V8eewlRe5fQnIDSHTlMnYctIqpSnIp1DOV9akOpOZHcIHGuCkm5Fl0my2syBpbnajnnSjPgSvV4HkZ0vy8Zf273o9SUhet8Wiclssy8ShMUkgVvp_aMMIQ8UBD-QQXrS6tfqqcDmt4ZgPIdrQulUDxwa--SSff29YwR13n2OZfvUfgr-GbebqGfvcY9EObFWLpX1DIKvSb5uZ9RsueST8
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwzV3db9MwED-NIbS98FFglE8jwSSkZSS24yZIPExlVUe3qdI6sbfgOI4oQwmqW6Hw__Cv8HdxzlfpECAeJvHSh9RxHPt897v47ncAz4QIekHipY6vdOBwgT-hRq9VqZgHfqKTkNsE56NjMTzlb8_8szX41uTC4CAM9mTKQ_wlu4D30l77mMl5qVe4sjmlvI6lHOniC3pq5vXBG1zW55QO9if9oVMXE3Ak6ui5w2IEx3HMGA01V1yhY6FtmqjkSsfoRCV-L_Gp5rHoMeYzhAVWvWsdoIUXrkwZ9nsFriL-odbH2-uftAqfuWEVKSmYwwLBmwy934za2kFlVu3gL-D2YozmT0ZvcAO-t9NVxrqc7y7m8a76eoFJ8r-fz5twvYbdZK_aJ7dgTWcduFYV4iw6sNFv6t51YHtcsXkXO2SyTE4zO2SbjJc838VtyPdL-g2cOSKzhJyUFYXQeBDs1hQZImszNSRPiSTjmT3WMPnMqUyMTshg5LuCWE4Y-_HsFRlL-2mH4F3knSwI-hKk_2mqzkk7tDtweilTdBfWszzT94AwhTg8oSLUDPeQjEMXjZjvSq2SOBWp7sILXNCo1j8mKkMLqBeVF-tVjupV7oLTSF70uaI0-Uv7p414Rvi-9kBJZjpfmMhiT4GQXbh_aEMRMYYe80QXtiqRbp_KbQav32NdCFaEvW1guc9X_8mmH0oOdMtUaDm17__Diz-BjeHk6DA6PDgePYBNais5u8yhwUNYn88W-hHCy3n8uNzcBN5ftvT_ALX-hAg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VIh4XHstreRoJKiE1JYkdb4LEodp21bJQRWoregu244ilKKnWWaHwj_gr_CrGeZUtAsShBy57yDqOY49nvolnvgF4xnk4ClMvcwKlQ4dx_Ik0eq1KSRYGqU4jZhOc3-3xnUP25ig4WoFvXS4MDsJgT6Y-xLe7-iTNWoYB76W9_ikXZa1bmLJ5payNp5zq6gt6a-b17hYu7XPfn2wfjHectqCAI1BPlw6VCJClpNSPNFNMoXOhbaqoYEpLdKTSYJQGvmaSjygNKEIDq-K1DtHKc1dkFPu9ABftSaH18zbH-73Sp27UREty6tCQsy5L7zejtrZQmWVb-AvAPRun-ZPhm1yH7_2U1fEuxxuLUm6or2fYJP-LOb0B11r4TTab_XITVnQ-gEtNQc5qAFfGXf27AazFDat3tU4OTpPUzDpZI_Ep33d1C4rtmoYDZ4-IPCX7dWUhNCIEuzVVjgjbzAwpMiJIPLfHG6aYO42p0SmZTAOXE8sNYz-ivSKxsJ94CN5F3ouKoE9Bxp9n6pj0Q7sNh-cyRXdgNS9yfQ8IVYjHU59HmuJeEjJy0ZgFrtAqlRnP9BBe4IImrR4ySR1i4HtJfbFd5aRd5SE4nfQlJw21yV_aP-1ENMH3tQdLItfFwiQWg3KE7tz9QxsfkWPkUY8P4W4j1v1Tmc3kDUZ0COGSwPcNLAf68j_57GPNhW4ZCy239v1_ePEncDnemiRvd_emD-Cqbws6u9Txw4ewWs4X-hGizFI-rvc3gQ_nLfw_AGA2hos
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficient+and+Selective+Biosynthesis+of+a+Precursor-Directed+FK506+Analogue%3A+Paving+the+Way+for+Click+Chemistry&rft.jtitle=Journal+of+natural+products+%28Washington%2C+D.C.%29&rft.au=Goranovi%C4%8D%2C+Du%C5%A1an&rft.au=Jenko%2C+Branko&rft.au=Ram%C5%A1ak%2C+Barbara&rft.au=Podgor%C5%A1ek+Berke%2C+Ajda&rft.date=2025-03-28&rft.eissn=1520-6025&rft.volume=88&rft.issue=3&rft.spage=619&rft_id=info:doi/10.1021%2Facs.jnatprod.4c00394&rft_id=info%3Apmid%2F40062573&rft.externalDocID=40062573
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0163-3864&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0163-3864&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0163-3864&client=summon